Arcus Biosciences, Inc. — Director's Dealing 2018

Mar 15, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2018-03-14

Reporting Person: Hadley Harbor Master Investors (Cayman) II L.P. (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series C Convertible Preferred Stock	$		Common Stock (1496813)		Direct

Footnotes

F1: Each share of Series C Convertible Preferred Stock is convertible into shares of common stock on a 1-for-1 basis at the option of the reporting person or upon the occurrence of certain events and has no expiration date. The Series C Convertible Preferred Stock reported in the table above reflects a 3.96-for-1 reverse stock split that was effected in connection with the Issuer's initial public offering.